Gainesville, FL5 Active Studies

Interstitial Lung Disease Clinical Trials in Gainesville, FL

Find 5 actively recruiting interstitial lung disease clinical trials in Gainesville, FL. Connect with local research sites and explore new treatment options.

5
Active Trials
4
Sponsors
5,010
Enrolling

Recruiting Interstitial Lung Disease Studies in Gainesville

About Interstitial Lung Disease Clinical Trials in Gainesville

Interstitial lung disease is a group of disorders characterized by progressive scarring of lung tissue, leading to breathlessness and reduced oxygen exchange. Causes include autoimmune diseases, environmental exposures, and unknown factors. Treatment includes antifibrotic medications and immunosuppressants.

There are currently 5 interstitial lung disease clinical trials recruiting participants in Gainesville, FL. These studies are seeking a combined 5,010 participants. Research is being sponsored by Duke University, Center for Violence Prevention Research Inc, GlaxoSmithKline and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Lung Disease Clinical Trials in Gainesville — FAQ

Are there interstitial lung disease clinical trials in Gainesville?

Yes, there are 5 interstitial lung disease clinical trials currently recruiting in Gainesville, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Gainesville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Gainesville research site will contact you about next steps.

Are clinical trials in Gainesville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Gainesville studies also compensate for your time and travel.

What interstitial lung disease treatments are being tested?

The 5 active trials in Gainesville are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial lung disease.

Data updated October 19, 2026 from ClinicalTrials.gov